While the ORR observed in the BRAF, c-MET, and KRAS altered NSCLC appeared to be similar to what had been observed in the non-selected NSCLC groups, the ORRs in the ALK and RET altered NSCLC groups were much lower (2). This evidence concerns the gene RET and non-small cell lung carcinoma.